Untitled Flashcards Set

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/13

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:05 AM on 12/10/24
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

14 Terms

1
New cards

Opioid overdose deaths

Rose significantly after 2010 following changes in the marketing and availability of OxyContin.

2
New cards

Purdue Pharma

Pharmaceutical company known for marketing OxyContin and involved in controversial practices around opioid prescriptions.

3
New cards

5th vital sign

Pain was promoted as the 5th vital sign by Sacklers, indicating a need to assess pain alongside traditional vital signs.

4
New cards

OxyContin

A prescription opioid medication that was marketed heavily by Purdue Pharma; characterized by time-release coating.

5
New cards

Pseudoaddiction

A condition where patients appear to be addicted to opioids but are actually in pain and require increased dosages.

6
New cards

Curtis Wright

FDA official who collaborated with Purdue Pharma on the licensing of OxyContin and later took a lucrative job with them.

7
New cards

Astroturf groups

Organizations that appear to be grassroots but are secretly funded by corporations, like the American Pain Foundation funded primarily by Purdue.

8
New cards

Opiophobia

The fear of prescribing opioids due to concerns about addiction and misuse.

9
New cards

Suboxone

Medication used to treat opioid use disorder, which has restrictions on concurrent substance use.

10
New cards

Methadone

Opioid used in treatment programs, often requiring in-person administration at clinics.

11
New cards

Sackler family

Owners of Purdue Pharma, involved in various controversies regarding the opioid crisis and philanthropy.

12
New cards

Settlement

The legal conclusion involving Purdue in which $10.4 billion was transferred to the Sacklers before the bankruptcy.

13
New cards

Emerging markets

Regions like India and China that Purdue Pharma aimed to expand opioid sales into, with significant financial strategies.

14
New cards

Nan Goldin’s campaign

Advocacy movement that pressured major art institutions to remove the Sackler name due to their involvement in the opioid crisis.